UA44542U - Method for treatment of resistant arterial hypertensia in patients suffering from hypertension - Google Patents

Method for treatment of resistant arterial hypertensia in patients suffering from hypertension

Info

Publication number
UA44542U
UA44542U UAU200903459U UAU200903459U UA44542U UA 44542 U UA44542 U UA 44542U UA U200903459 U UAU200903459 U UA U200903459U UA U200903459 U UAU200903459 U UA U200903459U UA 44542 U UA44542 U UA 44542U
Authority
UA
Ukraine
Prior art keywords
dose
pill
treatment
patients suffering
hypertension
Prior art date
Application number
UAU200903459U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Наталия Витальевна Кузьминова
Original Assignee
Винницкий Национальный Медицинский Университет Им. Н.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Винницкий Национальный Медицинский Университет Им. Н.И. Пирогова filed Critical Винницкий Национальный Медицинский Университет Им. Н.И. Пирогова
Priority to UAU200903459U priority Critical patent/UA44542U/en
Publication of UA44542U publication Critical patent/UA44542U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for treatment of resistant arterial hypertensia in patients suffering from hypertension consists in the performing of combined antihypertensive therapy with Enalapril maleate (Reniteku®) at a dose of 1 pill (20 mg) in the morning and Hydrochlorthiazide at a dose of 1 pill (12.5 mg) in the morning (or the fixed combination of Enalapril maleate at a dose of 20 mg and Hydrochlorthiazide at a dose of 12.5 mg is prescribed in the morning), Nebivolol (Nebiletu®) at a dose of 10 mg at 12o'clock, Amlodipine besylate (Norvasku®) at a dose of 1 pill (10 mg) at 18o'clock, Enalapril maleate (Reniteku®) at a dose of 1 pill (20 mg) in the evening at 20o'clock for permanent long-term ingestion.
UAU200903459U 2009-04-10 2009-04-10 Method for treatment of resistant arterial hypertensia in patients suffering from hypertension UA44542U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200903459U UA44542U (en) 2009-04-10 2009-04-10 Method for treatment of resistant arterial hypertensia in patients suffering from hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200903459U UA44542U (en) 2009-04-10 2009-04-10 Method for treatment of resistant arterial hypertensia in patients suffering from hypertension

Publications (1)

Publication Number Publication Date
UA44542U true UA44542U (en) 2009-10-12

Family

ID=50636555

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200903459U UA44542U (en) 2009-04-10 2009-04-10 Method for treatment of resistant arterial hypertensia in patients suffering from hypertension

Country Status (1)

Country Link
UA (1) UA44542U (en)

Similar Documents

Publication Publication Date Title
EP2444072A3 (en) Non-mucoadhesive film dosage forms
RU2009148278A (en) The use of estriol in a low dose
TW200621765A (en) Substituted phenylaminothiazoles and their use
GB2435166B (en) High molecular weight polphenols extracted from fermented tea and a method of manufacturing a medicament for the prevention and treatment of diabetes
WO2007136845A3 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
WO2007142811A3 (en) Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
WO2007038596A3 (en) Phytosterol nutritional supplements
SG158183A1 (en) Sesamin/episesamin compositions
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
NO20080244L (en) Dosage control for prasugrel
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
UA44542U (en) Method for treatment of resistant arterial hypertensia in patients suffering from hypertension
WO2011022633A3 (en) Method of threating cancer
MXPA03006477A (en) Method of treatment of type i diabetes.
UA85548C2 (en) Use of aqueous extract of red vine leaves for preventing transition from clinically insignificant early stages of chronic venous insufficiency to stages i, ii or iii
NO20072687L (en) Pharmaceutical contraceptive preparation
UA45323U (en) Method for correction of dislipidemy in patients suffering from the podagra
UA44238U (en) Method for treatment of chronic vascular diseases of intestine in patients suffering from the coronary heart disease and essential hypertension
Trelour Multivitamins
UA62613U (en) method for correction of nephropathy in patients with essential hypertension with paradoxical blood pressure reactivity
EE200400069A (en) Use of citalopram in the preparation of pharmaceutical compositions for the treatment of hypertension
UA67497A (en) Method for correcting metabolism of vascular endothelial growth factor in patients with hypertension
Jin-Ah et al. A prognosis evaluation after iliac bone graft in cleft alveolus patients
Farschtschi Hyoertension and proteinuria: 3 case reports
WO2008070308A3 (en) Method and composition of a carminative herb or natural supplement to decrease the adverse effects of orlistat, an oral lipase inhibitor, and a method with formulations to concurrently reduce fracture risk and insure appropriate fatsoluble vitamin supplementation when using orlistat, an oral lipase inhibitor, and a method o